PureTech Health PTCHF Stock
PureTech Health Price Chart
PureTech Health PTCHF Financial and Trading Overview
| PureTech Health stock price | 1.48 USD |
| Previous Close | 1.51 USD |
| Open | 1.8 USD |
| Bid | 1.39 USD x 520000 |
| Ask | 1.53 USD x 10000 |
| Day's Range | 1.8 - 1.8 USD |
| 52 Week Range | 1.45 - 1.92 USD |
| Volume | 4.86K USD |
| Avg. Volume | 560 USD |
| Market Cap | 438.15M USD |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PTCHF Valuation Measures
| Enterprise Value | 352.03M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 68.83782 |
| Price/Book (mrq) | 1.1342155 |
| Enterprise Value/Revenue | 55.307 |
| Enterprise Value/EBITDA | -3.477 |
Trading Information
PureTech Health Stock Price History
| Beta (5Y Monthly) | 0.81 |
| 52-Week Change | -11.17% |
| S&P500 52-Week Change | 17.38% |
| 52 Week High | 1.92 USD |
| 52 Week Low | 1.45 USD |
| 50-Day Moving Average | 1.57 USD |
| 200-Day Moving Average | 1.67 USD |
PTCHF Share Statistics
| Avg. Volume (3 month) | 560 USD |
| Avg. Daily Volume (10-Days) | 1.18K USD |
| Shares Outstanding | 243.42M |
| Float | 145.03M |
| Short Ratio | N/A |
| % Held by Insiders | 9.99% |
| % Held by Institutions | 57.46% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 33.21% |
| Operating Margin (ttm) | -1470.36% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -10.79% |
| Return on Equity (ttm) | 0.38% |
Income Statement
| Revenue (ttm) | 6.37M USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | 92.20% |
| Gross Profit (ttm) | -59064000 USD |
| EBITDA | -101248000 USD |
| Net Income Avi to Common (ttm) | 2.11M USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 231.52M USD |
| Total Cash Per Share (mrq) | 0.95 USD |
| Total Debt (mrq) | 222.73M USD |
| Total Debt/Equity (mrq) | 58.69 USD |
| Current Ratio (mrq) | 4.599 |
| Book Value Per Share (mrq) | 1.587 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -83631000 USD |
| Levered Free Cash Flow (ttm) | -94309000 USD |
Profile of PureTech Health
| Country | United States |
| State | MA |
| City | Boston |
| Address | 6 Tide Street |
| ZIP | 02210 |
| Phone | 617 482 2333 |
| Website | https://www.puretechhealth.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 90 |
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.
Q&A For PureTech Health Stock
What is a current PTCHF stock price?
PureTech Health PTCHF stock price today per share is 1.48 USD.
How to purchase PureTech Health stock?
You can buy PTCHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PureTech Health?
The stock symbol or ticker of PureTech Health is PTCHF.
Which industry does the PureTech Health company belong to?
The PureTech Health industry is Biotechnology.
How many shares does PureTech Health have in circulation?
The max supply of PureTech Health shares is 243.42M.
What is PureTech Health Price to Earnings Ratio (PE Ratio)?
PureTech Health PE Ratio is now.
What was PureTech Health earnings per share over the trailing 12 months (TTM)?
PureTech Health EPS is 0 USD over the trailing 12 months.
Which sector does the PureTech Health company belong to?
The PureTech Health sector is Healthcare.
